Clinical Trial Update: Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma

View source ↗

Summary

This is an ongoing clinical trial sponsored by Nanfang Hospital/Southern Medical University evaluating whether plasma sphingolipid metabolites can serve as biom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hepatocellular Carcinoma, Radiotherapy | Status: RECRUITING